Granahan Investment Management, LLC Collegium Pharmaceutical, Inc Transaction History

Granahan Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $1.15 Million - $1.74 Million	-74,047 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$13.89 - $25.45 $803,675 - $1.47 Million	57,860 Added 357.45%	74,047 $1.21 Million
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $262,353 - $545,302	-24,519 Reduced 60.23%	16,187 $333,000
Q3 2019 Nov 15, 2019	SELL	$10.16 - $13.28 $1.23 Million - $1.61 Million	-121,507 Reduced 74.91%	40,706 $467,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $360,219 - $562,716	-33,919 Reduced 17.29%	162,213 $2.13 Million
Q1 2019 May 14, 2019	BUY	$13.58 - $18.72 $156,156 - $215,261	11,499 Added 6.23%	196,132 $2.97 Million
Q4 2018 Feb 13, 2019	SELL	$14.78 - $19.68 $183,331 - $244,110	-12,404 Reduced 6.3%	184,633 $3.17 Million
Q3 2018 Nov 13, 2018	BUY	$14.16 - $24.3 $985,210 - $1.69 Million	69,577 Added 54.59%	197,037 $2.9 Million
Q2 2018 Aug 15, 2018	BUY	$21.79 - $28.29 $1.83 Million - $2.37 Million	83,860 Added 192.34%	127,460 $3.04 Million
Q1 2018 May 14, 2018	BUY	$18.15 - $29.21 $791,339 - $1.27 Million	43,600 New	43,600 $1.11 Million

255

38.6M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.